Abstract
Breast Cancer (BC) is associated with a substantial economic burden; however, real-world data regarding this burden for the Colombian Health System is very scarce. This study aims to describe the economic burden borne by the Health System in patients with BC affiliated with the contributory regime, which provides healthcare services to almost half of Colombian population, in 2019.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
